کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3053591 | 1580010 | 2015 | 21 صفحه PDF | دانلود رایگان |
• For many childhood brain tumour survivors, survival means chronic disease.
• For CBTS, QoS assessment should include tumour-, treatment- and host-related factors.
• Many CBTSs' dilemma: treatment takes CNS tumour, but bates CNS function.
• Predictive markers of late effects are needed for individual treatment planning.
• Empowering survivors and stakeholders: a new mission in Paediatric Neurooncology.
BackgroundTumours of the central nervous system (CNS) are the most frequent solid tumours and the second most frequent type of cancer in children and adolescents. Overall survival has continuously improved in Germany, since an increasing number of patients have been treated according to standardised, multicentre, multimodal treatment recommendations, trials of the German Paediatric Brain Tumour Consortium (HIT-Network) or the International Society of Paediatric Oncology-Europe (SIOP-E) during the last decades. Today, two out of three patients survive. At least 8000 long-term childhood brain tumour survivors (CBTS) are currently living in Germany. They face lifelong disease- and treatment-related late effects (LE) and associated socioeconomic problems more than many other childhood cancer survivors (CCS).MethodWe review the LE and resulting special needs of this particular group of CCS.ResultsDespite their increasing relevance for future treatment optimisation, neither the diversity of chronic and cumulative LE nor their pertinent risk factors and subsequent impact on quality of survival have yet been comprehensively addressed for CBTS treated according to HIT- or SIOP-E-protocols. Evidence-based information to empower survivors and stakeholders, as well as medical expertise to manage their individual health care, psychosocial and educational/vocational needs must still be generated and established.ConclusionThe establishment of a long-term research- and care network in Germany shall contribute to a European platform, that aims at optimising CBTSs' transition into adulthood as resilient individuals with high quality of survival including optimal levels of activity, participation and acceptance by society.
Journal: European Journal of Paediatric Neurology - Volume 19, Issue 6, November 2015, Pages 619–639